Nusinersen (Spinraza) will become available on the PBS from 1 June for the treatment of infantile and childhood-onset spinal muscular atrophy (SMA) in patients 18 years or under at initiation of treatment. However relief for affected families kicks in before then, according to Federal Health Minister Greg Hunt. “I want to thank Biogen for immediately opening ...
PBS win to families affected by SMA
By Mardi Chapman
8 May 2018